MSP Singapore Company

MSD Singapore, legally operating as MSP (Singapore) Pte. Ltd., is the Singaporean subsidiary of the global pharmaceutical giant Merck & Co., Inc. (known as MSD outside the U.S. and Canada). The company serves as a vital regional hub, overseeing commercial operations, clinical research, and large-scale manufacturing for the Asia-Pacific market. MSD Singapore is a leader in oncology, driven by its blockbuster immunotherapy Keytruda, and maintains a dominant position in the global vaccine market with products like Gardasil 9 and Vaxneuvance. Its state-of-the-art manufacturing facilities in Tuas are integral to the global production of active pharmaceutical ingredients and finished medicines. Through strategic partnerships with local institutions like A*STAR, the company actively contributes to Singapore's growing biotechnology ecosystem. MSD Singapore remains dedicated to addressing unmet medical needs in infectious diseases, cardiometabolic health, and various cancers.